OPT

Opthea Limited American Depositary Shares (OPT)

About Opthea Limited American Depositary Shares (OPT)

Opthea Ltd. is a clinical stage biopharmaceutical company, which engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It focuses on treating neovascular age-related macular degeneration and diabetic macular edema, which causes visual impairment among elderly and diabetic patients. The company was founded on October 17, 1984, and is headquartered in South Yarra, Australia.

Details

Daily high

$4.76

Daily low

$4.59

Price at open

$4.69

52 Week High

$4.91

52 Week Low

$1.60

Market cap

724.6M

Dividend yield

0.00%

Volume

26,089

Avg. volume

36,626

P/E ratio

-1.77

Opthea Limited American Depositary Shares News